Co-diagnostics, inc. ceo discusses company strategy for the future with yahoo! finance

Salt lake city, march 31, 2021 /prnewswire/ -- the ceo of co-diagnostics, inc. (nasdaq: codx), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, appeared yesterday on yahoo! finance to comment on the company's recently-released fy2020 earnings report, and to discuss its going-forward strategy as the world struggles to achieve normalization.
CODX Ratings Summary
CODX Quant Ranking